99% Purity : Manufactured with 99% purity , GLP-1 R (50mg) ensures the highest quality for preclinical studies , clinical trials , and metabolic health research , offering consistent and reliable results
These drug manufacturers didnt share these findings with doctors so that they could adjust their patients dosage, which would have potentially reduced their risk for this condition
Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al
It is a single-dose, controlled research exposure in a small sample, which cannot predict the effects of repeated, unsupervised cannabis use.What risks does this study not address?It does not address mood destabilization, mania or hypomania risk, psychosis risk, sleep, medication interactions, or cannabis use disorder, all established concerns in bipolar disorder.Should patients change their cannabis use based on this study?No
Abstract Recent FDA approval of new GLP-1 agonists drugs focused on weight loss has been met with a surge in use of drugs such as Wegovy and Zebound